| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli M Di Nicola, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, ... Blood, The Journal of the American Society of Hematology 99 (10), 3838-3843, 2002 | 4380 | 2002 |
| Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy S Siena, R Schiavo, P Pedrazzoli, C Carlo-Stella Journal of Clinical Oncology 18 (6), 1360-1377, 2000 | 419 | 2000 |
| Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial. PF Caimi, W Ai, JP Alderuccio, KM Ardeshna, M Hamadani, B Hess, ... Lancet Oncol 22 (6), 790-800, 2021 | 362 | 2021 |
| Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells J Reichel, A Chadburn, PG Rubinstein, L Giulino-Roth, W Tam, Y Liu, ... Blood 125 (7), 1061-1072, 2015 | 359 | 2015 |
| Glofitamab, a novel, bivalent CD20-targeting T-cell–engaging bispecific antibody, induces durable complete remissions in relapsed or refractory B-cell lymphoma: a phase I trial M Hutchings, F Morschhauser, G Iacoboni, C Carlo-Stella, FC Offner, ... Journal of Clinical Oncology 39 (18), 1959-1970, 2021 | 325 | 2021 |
| Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) AM Gianni, M Magni, M Martelli, M Di Nicola, C Carlo-Stella, S Pilotti, ... Blood 102 (2), 749-755, 2003 | 290 | 2003 |
| Glofitamab for relapsed or refractory diffuse large B-cell lymphoma MJ Dickinson, C Carlo-Stella, F Morschhauser, E Bachy, P Corradini, ... New England Journal of Medicine 387 (24), 2220-2231, 2022 | 287 | 2022 |
| Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma V Spina, A Bruscaggin, A Cuccaro, M Martini, M Di Trani, G Forestieri, ... Blood 131, 2413-2425, 2018 | 285 | 2018 |
| Therapy of molecular relapse in acute promyelocytic leukemia FL Coco, D Diverio, G Avvisati, MC Petti, G Meloni, EM Pogliani, A Biondi, ... Blood, The Journal of the American Society of Hematology 94 (7), 2225-2229, 1999 | 279 | 1999 |
| Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after PD-1 Blockade in Relapsed/Refractory Lymphoma RW Merryman, HT Kim, PL Zinzani, C Carlo-Stella, SM Ansell, ... Blood 129, 1380-1388, 2017 | 256 | 2017 |
| Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. C Carlo-Stella, A Ganser, D Hoelzer Journal of Clinical Investigation 80 (2), 286-293, 1987 | 207 | 1987 |
| Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells A Ganser, C Carlo-Stella, J Greher, B Volkers, D Hoelzer | 205 | 1987 |
| Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis. Trabanelli S, Chevalier MF, Martinez-Usatorre A, Gomez-Cadena A, Salomé B ... Nat Commun 8 (1), 593, 2017 | 197 | 2017 |
| Cell therapy: achievements and perspectives C Bordignon, C Carlo-Stella, MP Colombo, A De Vincentiis, L Lanata, ... Haematologica 84 (12), 1110-1149, 1999 | 186 | 1999 |
| Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide L Castagna, R Crocchiolo, S Furst, S Bramanti, J El Cheikh, B Sarina, ... Biology of Blood and Marrow Transplantation 20 (5), 724-729, 2014 | 175 | 2014 |
| Role of naive-derived T memory stem cells in T cell reconstitution following allogeneic transplantation A Roberto, L Castagna, V Zanon, S Bramanti, R Crocchiolo, JE McLaren, ... Blood 125, 2855-2864, 2015 | 165 | 2015 |
| Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma M Hamadani, J Radford, C Carlo-Stella, PF Caimi, E Reid, OA O’Connor, ... Blood, The Journal of the American Society of Hematology 137 (19), 2634-2645, 2021 | 155 | 2021 |
| Limited engraftment capacity of bone marrow–derived mesenchymal cells following T-cell–depleted hematopoietic stem cell transplantation D Cilloni, C Carlo-Stella, F Falzetti, G Sammarelli, E Regazzi, S Colla, ... Blood, The Journal of the American Society of Hematology 96 (10), 3637-3643, 2000 | 155 | 2000 |
| Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a … M Di Nicola, R Zappasodi, C Carlo-Stella, R Mortarini, SM Pupa, M Magni, ... Blood, The Journal of the American Society of Hematology 113 (1), 18-27, 2009 | 154 | 2009 |
| Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death R Zappasodi, SM Pupa, GC Ghedini, I Bongarzone, M Magni, AD Cabras, ... Cancer research 70 (22), 9062-9072, 2010 | 150 | 2010 |
Alessandro GianniIEO, University of Milan在 unimi.it 的电子邮件经过验证
